|

Darolutamide Oral Tablet Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Santa Chiara Hospital1

Indications

  • Hormone Sensitive Prostate Cancer1
  • Metastatic Tumor1
  • Prostate Cancer1
  • Cancer1

Other1 trial

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.